MedTrace Logo

Treatment of Chronic Laryngitis With Amitriptyline

NCT02552225 · Status: TERMINATED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2021-10-29

Study results available
· View outcomes & findings →

Summary

This randomized, double-blind, placebo-controlled trial will compare the effectiveness of amitriptyline versus placebo (inactive medication) in treating chronic laryngitis.

Conditions

  • Laryngeal Diseases

Interventions

DRUG

Amitriptyline

Subjects in this arm will receive pills composed of amitriptyline and Avicel (cellulose filler)

OTHER

Placebo

Subjects in this arm will receive pills composed only of Avicel (cellulose filler)

Sponsors & Collaborators

  • Boston Medical Center

    lead OTHER

Principal Investigators

  • J. Pieter Noordzij, MD · Boston Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-30
Primary Completion
2021-01-15
Completion
2021-01-15
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02552225 on ClinicalTrials.gov